Below is an image of an Eli Lilly letter which informs doctors in the UK that Prozac is no longer authorized for use in (so-called) premenstrual dysphoric disorder (PMDD). For a larger view, please click on the image.
September 5, 2002. OHRP Backtracks on Public Disclosure – Bureau of National Affairs FYI In Aug. 2000, when the Office of Human Research Protections replaced the former Office of Protection from Research Risks there was much talk about openness, accessibility, transparency and public accountability. One new feature was the posting…
Experiment infects AIDS patients in China with malaria Mon, 17 Feb 2003 The Cincinnati Enquirer reports that two prominent AIDS researchers at UCLA are being investigted for “taking part in a controversial medical experiment with Cincinnati physician Henry Heimlich to infect AIDS patients in China with malaria.” The experiments purportedly…
FDA Rejects Crestor Petition–Sacrificing Patient safety Tue, 15 Mar 2005 The FDA’s safety standard for allowing a drug to be marketed has been turned on its head. The law requires that a manufacturer provide scientific proof that a drug is safe and effective before it can be licensed for marketing….
Lawsuits & press info RE: SSRI addiction / suicide risk–not scientific literature Fri, 25 Oct To gain knowledge about the scope of a serious threat to public health–i.e., severe adverse drug effects of antidepressant drugs– physicians and consumers must turn to the popular and alternative press, rather than “peer reviewed”…
FDA Protects Pfizer: Removes Advisory Panelist for Citing Evidence Bextra Similar to Vioxx – WSJ Fri, 12 Nov 2004 Even as the Vioxx casualties are still being counted, even as FDA’s conduct is under Congressional investigation, the FDA office of new drugs has taken action to obstruct evidence-based safety evaluation…
University of Washington Violated Federal Protections for Human Research Subjects Thu, 21 Apr 2005 A major research scandal reveals that the University of Washington in Seattle is in gross systemic violations of federal research regulations. Experiments that were conducted on vulnerable populations – including, pregnant women, neonates, children, prisoners–should never…
